MARKET

AWKNF

AWKNF

Awakn Life Scien
OTCMQB
0.349
+0.069
+24.64%
Closed 14:00 11/25 EST
OPEN
0.349
PREV CLOSE
0.280
HIGH
0.349
LOW
0.349
VOLUME
2.50K
TURNOVER
873
52 WEEK HIGH
2.710
52 WEEK LOW
0.183
MARKET CAP
9.39M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
Benzinga · 3d ago
Awakn Life Sciences Announces Location for Larger Oslo Clinic
Awakn's Nordic expansion begins with new Awakn Clinics Oslo Toronto, Ontario--(Newsfile Corp. - November 23, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a revenue-generating biotechnology company researching, developi...
Newsfile · 4d ago
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Benzinga · 11/15 16:46
Awakn Life Sciences Signs Its Third Licensing Partnership Agreement in North America, and First in New York
Awakn will Partner with Nushama, One of New York's Leading Ketamine-assisted Therapy Centers Toronto, Ontario--(Newsfile Corp. - November 9, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a revenue-generating biotechnolo...
Newsfile · 11/09 12:30
Awakn Life Sciences Secures Funding to Expand Nordic Commercial Operations
Awakn has raised approx. CAD$775K to grow its Nordic clinics business Toronto, Ontario--(Newsfile Corp. - October 25, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a revenue-generating biotechnology company researching,...
Newsfile · 10/25 11:30
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats
(Part four of a four-part series) The reason why companies offering psychedelic-assisted therapy only use ketamine is that at the moment it is the only one that holds a medical license. While psilocybin and MDMA are showing enormous promise, they are still in clinical research stages.
Benzinga · 10/13 15:25
Can Ketamine Treat Alcohol Addiction? The Awakn Approach
(Part three of a four-part series)
Benzinga · 10/10 14:24
Can Ketamine Treat Alcohol Addiction? How Therapy Actually Functions?
(Part two of a four-part series)
Benzinga · 10/03 16:10
More
About AWKNF
Awakn Life Sciences Corp. is a Canada-based biotechnology company. The Company is engaged in the research, development, and delivery of psychedelic therapeutics (medicines and therapies) to treat addiction. The Company’s therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than traditional single drug receptor targets. It operates through three segments: the development segment, delivery segment, and corporate segment. The development segment, which focuses on researching and developing psychedelic drugs and therapies, ketamine-assisted psychotherapy and methylenedioxymethamphetamine (MDMA)assisted psychotherapy to treat substance and behavioral addictions. The delivery segment, which includes a chain of medical psychedelic clinics across Europe. The corporate segment, which comprises corporate income and expense items. The Company operates in the United Kingdom (UK), Norway, Ireland, and Canada.

Webull offers kinds of Awakn Life Sciences Corp stock information, including OTCMQB:AWKNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWKNF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AWKNF stock methods without spending real money on the virtual paper trading platform.